Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Cash Flow from Operations

Arbutus Biopharma Cp Cash Flow from Operations Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Cash Flow from Operations from 2010 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Cash Flow from Operations for the last 12 months ending December 12, 2018 was $-68m a 24.78% decrease of -17m year over year
  • Arbutus Biopharma Cp Annual Cash Flow from Operations for 2018 was $-68m a 28.42% decrease of -19m from 2017
  • Arbutus Biopharma Cp Annual Cash Flow from Operations for 2017 was $-49m a -19.10% increase of 9m from 2016
  • Arbutus Biopharma Cp Annual Cash Flow from Operations for 2016 was $-58m a 2.60% decrease of -2m from 2015
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Cash Flow from Operations Data

12/2018$-17m
09/2018$-13m
06/2018$-18m
03/2018$-20m
12/2017$-10m
09/2017$-16m
06/2017$-5m
03/2017$-18m
12/2016$-15m
09/2016$-15m

Annual ABUS Cash Flow from Operations Data

2018$-68m
2017$-49m
2016$-58m
2015$-56m
2014$-12m
2013$-7m
2012$33m
2011$-8m
2010$-11m
2009$-5m